Skip to content
Home/Companies/Healthcare/GreyWolf Therapeutics
GT

GreyWolf Therapeutics

Healthcare·UK·Active·8yr hold

GreyWolf Therapeutics is a healthcare company, headquartered in United Kingdom.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns GreyWolf Therapeutics?

GreyWolf Therapeutics is currently owned by Andera Partners through BioDiscovery 5 (2017 vintage), since 2018.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 5 · 2017 · VC

Key facts

HQUnited Kingdom
SectorHealthcare

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Exited 2024
HealthcareFrance· 2021
to
Evommune
Exited 2025
HealthcareFrance· 2021
to
Nyxoah
Active
HealthcareBelgium· 2020
AgoMab
Exited 2026
HealthcareFrance· 2019
to
AM Pharma
Active
HealthcareNetherlands· 2019
Arvelle
Exited 2021
HealthcareSwitzerland· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings